Cited by 366Health Systems, Economic Evaluations, Quality of LifeMeta-analysis and systematic reviewsDelphi Technique in Research

The DOI matches its Crossref record; 74 of the 76 references it cites were found in a registry or an index.

Examining the Value and Quality of Health Economic Analyses: Implications of Utilizing the QHES

Open access

Ofman, Joshua J., Sullivan, Sean D., Neumann, Peter J., Chiou, Chiun-Fang, Henning, James M., Wade, Sally W., Hay, Joel W.·2003·Journal of Managed Care Pharmacy

DOI 10.18553/jmcp.2003.9.1.53PMC PMC10437166

Open this paper in CoChat — free account Open PDF

Abstract

OBJECTIVE: To examine the increasing use of health economic studies and practical implications of evaluating their quality utilizing the Quality of Health Economic Studies (QHES) instrument. METHODS: We first reviewed secondary references to examine ways in which health economic analyses are used in different health care settings, the manner in which these data are appraised and evaluated, and their relevance and value in decision making. The QHES, a new instrument designed to support fast, accurate initial assessments of study quality, was then introduced and validated. A case study was performed using the QHES to score the quality of 30 cost-effectiveness studies in gastroesophageal reflux disease (GERD) published since 1985. Areas where additional research could guide efforts to identify and enhance the use of higher-quality cost-effectiveness studies were suggested. RESULTS: Results from the published validation study of the QHES demonstrated the validity of this new instrument. The resulting QHES scores in the case study of GERD papers ranged from 43 to 91 with a mean of 63.6 (SD=14.7). Approximately 27% of the studies rated had scores less than 50, and 27% had scores above or equal to 75. All 30 studies made conclusions and recommendations and justified them based on their study results. Most studies used appropriate cost and health outcome measures. Very few studies stated the perspective of their analysis and reasons for its selection. The majority of the studies did not perform incremental analysis. CONCLUSION: An examination of the QHES validation study and the case study in GERD suggests that there is a rationale and potential utility to use a quality scoring system for cost-effectiveness studies. The QHES may play an important role in discriminating higher-quality cost-effectiveness information to enhance decision making. The QHES can also serve as a guideline for conducting and reporting future cost-effectiveness studies, as an aid in the editorial process, and for stratification in systematic reviews. Complex decisions regarding resource allocation rarely rely solely on economic considerations but do increasingly use health economic analyses. To the extent that such analyses are used, the QHES may help ensure that higher-quality analyses receive more analytic attention and greater weight in the decision-making process.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.18553/jmcp.2003.9.1.53

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?
Moher, D., Pham, B., Jones, A., Cook, D. J., Jadad, A. R., Moher, M., Tugwell, P., & Klassen, T. P. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01085-x · Cited by 3,560
Users' Guides to the Medical Literature
Guyatt, G. H. (1993) · JAMA · doi:10.1001/jama.270.17.2096 · Cited by 3,083
Recommendations of the Panel on Cost-Effectiveness in Health and Medicine
Weinstein, M. C. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540150055031 · Cited by 2,455 · cited 1×
“Weinstein et al., 1996.”
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
Jüni, P. (1999) · JAMA · doi:10.1001/jama.282.11.1054 · Cited by 1,981
Guidelines for authors and peer reviewers of economic submissions to the BMJ
Drummond, M. F., & Jefferson, T. O. (1996) · BMJ · doi:10.1136/bmj.313.7052.275 · Cited by 1,827
Assessing the quality of randomized controlled trials: An annotated bibliography of scales and checklists
Moher, D., Jadad, A. R., Nichol, G., Penman, M., Tugwell, P., & Walsh, S. (1995) · Controlled Clinical Trials · doi:10.1016/0197-2456(94)00031-w · Cited by 1,308
The Role of Cost-effectiveness Analysis in Health and Medicine
Russell, L. B. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540140060028 · Cited by 1,167
Are Guidelines Following Guidelines?
Shaneyfelt, T. M., Mayo‐Smith, M. F., & Rothwangl, J. (1999) · JAMA · doi:10.1001/jama.281.20.1900 · Cited by 853
Cost-effectiveness analysis.
Robinson, R. (1993) · BMJ · doi:10.1136/bmj.307.6907.793 · Cited by 819

Show all 76 references

Research works printed but not linked: 19

Shaneyfelt TM, Mayo-Smith MF, Rothwangl J. Are guidelines following guide- lines? The methodological quality of clinical practice guidelines in the peer- reviewed medical literature. JAMA. 1999;281:1900-05.
Drummond MF, Richardson WS, O'Brien BJ, et al. User' s guide to the medical literature. XIII. How to use an article on economic analysis of clinical practice. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA. 1997; 277:1552-57.
O'Brien B, Heyland D, Richardson WS, et al. User' s guide to the medical litera- ture. XIII. How to use an article on economic analysis of clinical practice. B. What are the results and will they help me in caring for my patients? JAMA.1997; 277:1802-06.
Sonnenberg A, Inadomi JM, Becker LA. Economic analysis of step-wise treat- ment of gastroesophageal reflux disease. Aliment Pharmacol Ther. 1999;13:1003-13.
Stalhammar NO. Assessing the cost-effectiveness of medical treatments in Examining the Value and Quality of Health Economic Analyses: Implications of Utilizing the QHES acid-related diseases. The Markov chain approach applied to a comparison between intermittent and maintenance treatment of reflux esophagitis. Scand J Gastroenterol Suppl. 1993;199:8-13.
Bate C, Richardson P. Cost-effectiveness of omeprazole in the management of gastroesophageal reflux disease in clinical practice. Br J Med Econ. 1994;7:81-97.
Bate C, Hungin A, Wilcock C. Cost-effective management of gastroesophageal reflux disease in general practice. Br J Med Econ. 1993;6:81-90.
Bate C, Green J, Taylor M. Cost-effective prophylaxis against the recurrence of benign oesophageal stricture. Br J Med Econ. 1995;8:97-107.
Bate C, Richardson P. A one-year model for the cost-effectiveness of treating reflux oesophagitis. Br J Med Econ. 1992;2:5-11.
Bate C. Cost-effectiveness of omeprazole in the treatment of reflux oesophagi- tis. Br J Med Econ. 1991;1:53-61.
Bate C, Richardson P. Symptomatic assessment and cost effectiveness of treat- ments for reflux oesophagitis: comparisons of omeprazole and histamine H2- receptor antagonists. Br J Med Econ. 1992;2:37-48.
Green J, Bate C, Copeman M. A comparison of the cost-effectiveness of omeprazole and ranitidine in reflux oesophagitis. Br J Med Econ. 1995;8:37-48.
Jonsson B, Stalhammar NO. The cost-effectiveness of omeprazole and raniti- dine in intermittent and maintenance treatment of reflux oesophagitis-the case of Sweden. Br J Med Econ. 1993;6:111-26.
Phillips C, Moore A. Trial and error-an expensive luxury: economic analysis of effectiveness of proton pump inhibitors and histamine antagonists in treating reflux disease. Br J Med Econ. 1997;11:55-63.
Bate C, Richardson P. Cost-effectiveness of 20 mg and 40 mg of omeprazole in oesophageal reflux disease. Br J Med Econ. 1993;6:59-66.
Torrance GW, Blaker D, Detsky A, et al. Canadian guidelines for economic evaluation of pharmaceuticals. Canadian Collaborative Workshop for Pharmacoeconomics. Pharmacoeconomics. 1996;9:535-59.
Economic analysis of health care technology. A report on principles. Task Force on Principles for Economic Analysis of Health Care Technology. Ann Intern Med. 1995;123:61-70.
Drummond M, O'Brien B, Stoddart G, Torrance GW. Critical Assessment of Economic Evaluation. Methods for the Economic Evaluation of Health Care Programmes. Oxford, England: Oxford Medical Publications; 1997:27-51.
Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ. 1996;313:275-83.

Sorted by citations

Items 101–200 of 366

Cost-effectiveness of Surgery in the Management of Metastatic Epidural Spinal Cord Compression
Fehlings, M. G., Nater, A., & Holmer, H. K. (2014) · Spine · doi:10.1097/brs.0000000000000525 · Cited by 28
Meta‐analysis of the cost‐effectiveness of early versus delayed cholecystectomy for acute cholecystitis
Gallagher, T. K., Kelly, M. E., & Hoti, E. (2019) · BJS Open · doi:10.1002/bjs5.50120 · Cited by 28
Cost-Utility Analyses in Spine Care
Nwachukwu, B. U., Schairer, W. W., Shifflett, G. D., Kellner, D. B., & Sama, A. A. (2014) · Spine · doi:10.1097/brs.0000000000000663 · Cited by 27
Cost-effectiveness analysis of Xpert in detecting Mycobacterium tuberculosis: A systematic review
Hao, X., Lou, H., Bai, J., Ding, Y., Yang, J., & Pan, W. H. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.078 · Cited by 27
Establishing Age-Specific Cost-Effective Annual Revision Rates for Unicompartmental Knee Arthroplasty: A Meta-Analysis
Chawla, H., Ghomrawi, H., van der List, J. P., Eggman, A. A., Zuiderbaan, H. A., & Pearle, A. D. (2016) · The Journal of Arthroplasty · doi:10.1016/j.arth.2016.08.019 · Cited by 27
Systematic Review of the Costs and Benefits of Prescribed Cannabis-Based Medicines for the Management of Chronic Illness: Lessons from Multiple Sclerosis
Herzog, S., Shanahan, M., Grimison, P., Tran, A. D., Wong, N., Lintzeris, N., Simes, R. J., Stockler, M. R., & Morton, R. L. (2017) · PharmacoEconomics · doi:10.1007/s40273-017-0565-6 · Cited by 27
Evaluating the Economics of Complementary and Integrative Medicine
Herman, P. M. (2013) · Global Advances in Health and Medicine · doi:10.7453/gahmj.2013.002 · Cited by 27
A review of cost–effectiveness of palivizumab for respiratory syncytial virus
Hussman, J. M., Li, A., Paes, B. A., & Lanctôt, K. L. (2012) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.12.45 · Cited by 26
Economic evaluations of clinical pharmacy services in the United States: 2011‐2017
Talon, B., Pérez, A., Yan, C. H., Alobaidi, A., Zhang, K. H., Schultz, B. G., Suda, K. J., & Touchette, D. R. (2019) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1199 · Cited by 26
Cost Effectiveness of Pharmacological Management for Osteoarthritis: A Systematic Review
Shi, J., Fan, K., Yan, L., Fan, Z., Li, F. Y., Wang, G., Liu, H., Liu, P., Yu, H., Li, J. J., et al. (2022) · Applied Health Economics and Health Policy · doi:10.1007/s40258-022-00717-0 · Cited by 26
The performance and publication of cost-utility analyses in plastic surgery: Making our specialty relevant
Thoma, A., Ignacy, T. A., Ziolkowski, N. I., & Voineskos, S. H. (2012) · Plastic Surgery · doi:10.1177/229255031202000319 · Cited by 26
Assessing the Quality of Pharmacoeconomic Studies in India
Desai, P. R., Chandwani, H. S., & Rascati, K. L. (2012) · PharmacoEconomics · doi:10.2165/11590140-000000000-00000 · Cited by 26
Cost-Effectiveness of Endovascular Versus Open Repair of Abdominal Aortic Aneurysm: A Systematic Review
Nargesi, S., Abutorabi, A., Alipour, V., Tajdini, M., & Salimi, J. (2021) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07130-6 · Cited by 25
Systematic Review of Cost-Effectiveness Analyses of Treatments for Psoriasis
Zhang, W., Islam, N., Ma, C., & Anis, A. H. (2014) · PharmacoEconomics · doi:10.1007/s40273-014-0244-9 · Cited by 25
Comprehensive Review of Methods to Assess Uncertainty in Health Economic Evaluations
Otten, T., Grimm, S. E., Ramaekers, B. L. T., & Joore, M. A. (2023) · PharmacoEconomics · doi:10.1007/s40273-023-01242-1 · Cited by 24
Economic impact of Juvenile Idiopathic Arthritis: a systematic review
Rodríguez, F. G., Gamboa-Alonso, A., Jiménez-Hernández, S., Ochoa-Alderete, L., Barrientos-Martínez, V. A., Álvarez‐Villalobos, N. A., Luna-Ruíz, G. A., Peláez-Ballestas, I. D. P., Villarreal-Treviño, A. V., de la O-Cavazos, M. E., et al. (2021) · Pediatric Rheumatology · doi:10.1186/s12969-021-00641-y · Cited by 24
Cost-Effectiveness and Impact on Health Care Utilization of Interventions to Improve Medication Adherence and Outcomes in Asthma and Chronic Obstructive Pulmonary Disease: A Systematic Literature Review
van Boven, J. F. M., Lavorini, F., Ágh, T., Sadatsafavi, M., Patino, O., & Muresan, B. (2024) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2023.12.049 · Cited by 24
Economic Considerations in the Use of Novel Targeted Therapies for Lung Cancer: Review of Current Literature
Albaba, H., Lim, C. H., & Leighl, N. B. (2017) · PharmacoEconomics · doi:10.1007/s40273-017-0563-8 · Cited by 24
Equity, acceptability and feasibility of using polyunsaturated fatty acids in children and adolescents with autism spectrum disorder: a rapid systematic review
on behalf of the ISACA guideline working group, D’Alò, G. L., Crescenzo, F. D., Minozzi, S., Morgano, G. P., Mitrova, Z., Scattoni, M. L., Amato, L., Davoli, M., & Schünemann, H. J. (2020) · Health and Quality of Life Outcomes · doi:10.1186/s12955-020-01354-8 · Cited by 23
Evidence-based decision-making in infectious diseases epidemiology, prevention and control: matching research questions to study designs and quality appraisal tools
Harder, T., Takla, A., Rehfuess, E. A., Sanchez‐Vivar, A., Matysiak‐Klose, D., Eckmanns, T., Krause, G., Gomes, H. D. C., Jansen, A., Ellis, S., et al. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-69 · Cited by 24
Complementary and alternative medicine in back pain utilization report.
Santaguida, P. L., Gross, A., Busse, J. W., Gagnier, J. J., Walker, K. L., Bhandari, M., & Raina, P. (2009) · PubMed Central · Cited by 23
A systematic review of health economic evaluation in adjuvant breast radiotherapy: Quality counted by numbers
Monten, C., Veldeman, L., Verhaeghe, N., & Lievens, Y. (2017) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2017.08.034 · Cited by 22
Allogenic Stem Cells in Spinal Fusion: A Systematic Review
Hsieh, P. C., Buser, Z., Skelly, A. C., Brodt, E., Brodke, D. S., Meisel, H.-J., Park, J., Yoon, S. T., & Wang, J. C. (2019) · Global Spine Journal · doi:10.1177/2192568219833336 · Cited by 22
Toward a Centralized, Systematic Approach to the Identification, Appraisal, and Use of Health State Utility Values for Reimbursement Decision Making: Introducing the Health Utility Book (HUB)
Xie, F., Zoratti, M. J., Chan, K., Husereau, D., Krahn, M. D., Levine, O. H., Clifford, T., Schünemann, H. J., & Guyatt, G. H. (2019) · Medical Decision Making · doi:10.1177/0272989x19837969 · Cited by 22
Cost Effectiveness of Monoclonal Antibody Therapy for Rare Diseases: A Systematic Review
Park, T., Griggs, S. K., & Suh, D. (2015) · BioDrugs · doi:10.1007/s40259-015-0135-4 · Cited by 22
Economic evaluation of next‐generation sequencing techniques in diagnosis of genetic disorders: A systematic review
Rezapour, A., Souresrafil, A., Barzegar, M., Sheikhy‐Chaman, M., & Tatarpour, P. (2023) · Clinical Genetics · doi:10.1111/cge.14313 · Cited by 21
The economics of dentistry: a neglected concern
Shariati, B., MacEntee, M. I., & Yazdizadeh, M. (2013) · Community Dentistry And Oral Epidemiology · doi:10.1111/cdoe.12047 · Cited by 21
Health economic evaluation of exercise interventions in people over 60 years old: A systematic review
Subías-Perié, J., Navarrete‐Villanueva, D., Gómez‐Cabello, A., Vicente‐Rodríguez, G., & Casajús, J. A. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.111713 · Cited by 21
Assessment of Pharmacoeconomic Evaluations Submitted for Reimbursement in Korea
Yim, E.-Y., Lim, S. H., Oh, M.-J., Park, H., Gong, J.-R., Park, S. E., & Yi, S. Y. (2012) · Value in Health · doi:10.1016/j.jval.2011.11.026 · Cited by 21
Cost-Effectiveness of Hip Arthroscopy for Treatment of Femoroacetabular Impingement Syndrome and Labral Tears: A Systematic Review
Go, C. C., Kyin, C., Chen, J. W., Domb, B. G., & Maldonado, D. R. (2021) · Orthopaedic Journal of Sports Medicine · doi:10.1177/2325967120987538 · Cited by 20
Modelling the cost-effectiveness of total knee arthroplasty: A systematic review
Kamaraj, A., To, K., Seah, M. K. T., & Khan, W. S. (2020) · Journal of Orthopaedics · doi:10.1016/j.jor.2020.10.003 · Cited by 20
Systematic critical review of previous economic evaluations of smoking cessation during pregnancy
Jones, M., Lewis, S., Parrott, S., & Coleman, T. J. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-008998 · Cited by 19
Methodological reviews of economic evaluations in health care: what do they target?
Hutter, F., Rodríguez‐Ibeas, R., & Antoñanzas, F. (2013) · The European Journal of Health Economics · doi:10.1007/s10198-013-0527-7 · Cited by 19
Weighing the evidence on costs and benefits of polygenic risk-based approaches in clinical practice: A systematic review of economic evaluations
Siena, L. M., Baccolini, V., Riccio, M., Rosso, A., Migliara, G., Sciurti, A., Isonne, C., Iera, J., Pierri, F., Marzuillo, C., et al. (2025) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2025.05.012 · Cited by 18
Cost Analysis in Shoulder Surgery: A Systematic Review
Tischer, T., Lenz, R., Breinlinger‐O’Reilly, J., & Lutter, C. (2020) · Orthopaedic Journal of Sports Medicine · doi:10.1177/2325967120917121 · Cited by 18
Economic considerations on the usage of biologics in the allergy clinic
Azzano, P., Dufresne, É., Poder, T. G., & Bégin, P. (2020) · Allergy · doi:10.1111/all.14494 · Cited by 20
Whether and How Disutilities of Adverse Events were Used in the Economic Evaluation of Drug Therapy for Cancer Treatment
Lu, Y., Dai, Z., Chang, F., Wang, L., He, J., Shi, P., Zhang, H., & Lu, Y. (2023) · PharmacoEconomics · doi:10.1007/s40273-022-01232-9 · Cited by 18
Cost-effectiveness analysis of anidulafungin for the treatment of candidaemia and other forms of invasive candidiasis
Auzinger, G. M., Playford, E. G., Graham, C. N., Knox, H. N., Weinstein, D. L., Kantecki, M., Schlamm, H. T., & Charbonneau, C. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1143-1 · Cited by 18
The cost effectiveness of palivizumab in congenital heart disease: a review of the current evidence
Hussman, J. M., Lanctôt, K. L., & Paes, B. A. (2012) · Journal of Medical Economics · doi:10.3111/13696998.2012.734886 · Cited by 18
Examining the quality of health economic analyses submitted to the Pharmaceutical Benefits Board in Sweden
Ramsberg, J., Odeberg, S., Engstr�m, A., & Lundin, D. (2004) · The European Journal of Health Economics · doi:10.1007/s10198-004-0246-1 · Cited by 18
Economic Evaluations of Thrombophilia Screening Prior to Prescribing Combined Oral Contraceptives: A Systematic and Critical Review
Vernon, E., Hiedemann, B. G., & Bowie, B. H. (2017) · Applied Health Economics and Health Policy · doi:10.1007/s40258-017-0318-x · Cited by 19
Evaluating quantity and quality of literature focusing on health economics and pharmacoeconomics in Gulf Cooperation Council countries
Eljilany, I., El‐Dahiyat, F., Curley, L. E., & Babar, Z. (2018) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2018.1479254 · Cited by 18
Cost-effectiveness of vaccination against herpes zoster
de Boer, P. T., Wilschut, J., & Postma, M. J. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.28670 · Cited by 17
A Systematic Review of Economic Evaluations of Active Tuberculosis Treatments
Byun, J., Kim, H., Lee, E., & Kwon, S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.736986 · Cited by 17
A Systematic Review on the Extent and Quality of Pharmacoeconomic Publications in Egypt
Farid, S. F., Elmahdawy, M., & Baines, D. L. (2018) · Clinical Drug Investigation · doi:10.1007/s40261-018-0730-5 · Cited by 17
The Cost Effectiveness of Implantable Cardioverter Defibrillators: A Systematic Review of Economic Evaluations
Gialama, F., Prezerakos, P. E., & Maniadakis, N. (2013) · Applied Health Economics and Health Policy · doi:10.1007/s40258-013-0069-2 · Cited by 17
Standardizing Quality Assessment of Observational Studies for Decision Making in Health Care
Brixner, D. L. (2009) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2009.15.3.275 · Cited by 17
La medición de la calidad de los estudios de evaluación económica: Una propuesta de "checklist" para la toma de decisiones
Perpiñán, J. M. A., Martínez, F. I. S., & Pérez, J. E. M. (2009) · Revista Española de Salud Pública · doi:10.1590/s1135-57272009000100006 · Cited by 17
Economic evaluations of peritoneal dialysis and hemodialysis: 2004-2012
Liu, F. X., Quock, T. P., Burkart, J., Noe, L. L., & Inglese, G. W. (2013) · F1000Research · doi:10.12688/f1000research.2-273.v1 · Cited by 16
Economic Evaluations Conducted for Assessment of Genetic Testing Technologies: A Systematic Review
Assasi, N., Schwartz, L. J., Tarride, J., Goeree, R. A., & Xie, F. (2012) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2012.0178 · Cited by 16
Biological Substitutes/Extenders for Spinal Arthrodesis
Hsu, W. K., Hashimoto, R. E., Berven, S., & Nassr, A. N. (2014) · Spine · doi:10.1097/brs.0000000000000548 · Cited by 16
A literature review to evaluate the clinical and economic value of olmesartan for the treatment of hypertensive patients
Kourlaba, G., Gialama, F., Tsioufis, K., & Maniadakis, N. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.06.115 · Cited by 16
A Systematic Review of Cost-Effectiveness of Non-Statin Lipid-Lowering Drugs for Primary and Secondary Prevention of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus
Abushanab, D., Al‐Badriyeh, D., Marquina, C., Bailey, C., Jaam, M. J., Liew, D., & Ademi, Z. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101211 · Cited by 15
Cost Effectiveness of Pharmacological and Non-pharmacological Treatments for Depression in Low- and Middle-Income Countries: A Systematic Literature Review
Belay, Y. B., Engel, L., Lee, Y. Y., Le, N., & Mihalopoulos, C. (2023) · PharmacoEconomics · doi:10.1007/s40273-023-01257-8 · Cited by 16
A Systematic Review of Methods Used by Pediatric Cost-Utility Analyses to Include Family Spillover Effects
Lamsal, R., Yeh, E. A., Pullenayegum, E., & Ungar, W. J. (2023) · PharmacoEconomics · doi:10.1007/s40273-023-01331-1 · Cited by 18
A population‐based analysis of attributable hospitalisation costs of invasive fungal diseases in haematological malignancy patients using data linkage of state‐wide registry and costing databases: 2009‐2015
Valentine, J. C., Morrissey, C. O., TACEY, M. A., Liew, D., Patil, S. S., & Ananda-Rajah, M. R. (2019) · Mycoses · doi:10.1111/myc.13033 · Cited by 16
Sponsorship Bias in Base-Case Values and Uncertainty Bounds of Health Economic Evaluations? A Systematic Review of Herpes Zoster Vaccination
Bilcke, J., Verelst, F., & Beutels, P. (2018) · Medical Decision Making · doi:10.1177/0272989x18776636 · Cited by 15
A systematic review of pharmacoeconomic evaluations of erlotinib in the first-line treatment of advanced non-small cell lung cancer
Nguyen, C. T. T., Petrelli, F., Scuri, S., Nguyen, B. T., & Grappasonni, I. (2019) · The European Journal of Health Economics · doi:10.1007/s10198-019-01040-7 · Cited by 15
Guidelines for reporting health economic research
Haddad, F. S., & McLawhorn, A. S. (2016) · The Bone & Joint Journal · doi:10.1302/0301-620x.98b2.37643 · Cited by 15
Evaluation of the economic benefits, administration times, and patient preferences associated with the use of biotechnological drugs administered subcutaneously and intravenously in patients with cancer: a systematic review
Parra, A., Hernandez, C. A., & Prieto‐Pinto, L. (2023) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2023.2249232 · Cited by 16
Research on Improving Outcomes and Reducing Costs of Psychological Interventions: Toward Delivering the Best to the Most for the Least.
Yates, B. (2020) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-071519-110415 · Cited by 12
Cost-effectiveness analyses in shoulder arthroplasty: a critical review using the Quality of Health Economic Studies (QHES) instrument
Cregar, W. M., Beletsky, A., Cvetanovich, G. L., Feeley, B. T., Nicholson, G. P., & Verma, N. N. (2020) · Journal of Shoulder and Elbow Surgery · doi:10.1016/j.jse.2020.07.040 · Cited by 14
Evidence of Chinese Herbal Medicine Use From an Economic Perspective: A Systematic Review of Pharmacoeconomics Studies Over Two Decades
Xiong, X., Jiang, X., Lv, G., Yuan, J., Li, M., & Lu, K. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.765226 · Cited by 14
Systematic literature review to evaluate and characterize the health economics and outcomes research studies in India
Mishra, D., & Nair, S. (2015) · Perspectives in Clinical Research · doi:10.4103/2229-3485.148802 · Cited by 14
Pharmacological Management of Chronic Lower Back Pain: A Review of Cost Effectiveness
Haas, M. R., & Lourenço, R. D. A. (2015) · PharmacoEconomics · doi:10.1007/s40273-015-0258-y · Cited by 14
From Evidence to Policy: Economic Evaluations of Healthcare in Malaysia: A Systematic Review
Rahim, K. N. K. A., Kamaruzaman, H. F., Dahlui, M., & Puteh, S. E. W. (2019) · Value in Health Regional Issues · doi:10.1016/j.vhri.2019.09.002 · Cited by 14
Economic Evaluation of Pharmacist-Led Digital Health Interventions: A Systematic Review
Park, T., Kim, H. M., Song, S., & Griggs, S. K. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191911996 · Cited by 15
Cost-effectiveness of first-line immunotherapy for advanced non-small cell lung cancer with different PD-L1 expression levels: A comprehensive overview
Wu, C., Li, W., Tao, H., Zhang, X., Yu, X., Song, R., Wang, K., Zuo, L., Cai, Y., Wu, H., et al. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.104195 · Cited by 13
A Systematic Review of the Costs of Drug‐Associated Acute Kidney Injury and Potential Cost Savings With Nephrotoxin Stewardship Prevention Strategies
Stottlemyer, B. A., Tran, T., Suh, K., & Kane‐Gill, S. L. (2024) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.3493 · Cited by 13
The quality of pharmacoeconomic evaluations of age-related macular degeneration therapeutics: a systematic review and quantitative appraisal of the evidence
Foster, W. J., Tufail, W., & Issa, A. M. (2010) · British Journal of Ophthalmology · doi:10.1136/bjo.2009.170282 · Cited by 13
Rush to Judgement: Imaginary Worlds and Cost-Outcomes Claims for PCSK9 Inhibitors
Langley, P. C. (2017) · INNOVATIONS in pharmacy · doi:10.24926/iip.v8i2.516 · Cited by 13
Cancers: What Are the Costs in Relation to Disability-Adjusted Life Years? A Systematic Review and Meta-Analysis
Garlasco, J., Nurchis, M. C., Bordino, V., Sapienza, M., Altamura, G., Damiani, G., & Gianino, M. M. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19084862 · Cited by 13
Mind the Gap! A Multilevel Analysis of Factors Related to Variation in Published Cost-Effectiveness Estimates within and between Countries
Boehler, C. E. H., & Lord, J. L. (2015) · Medical Decision Making · doi:10.1177/0272989x15579173 · Cited by 13
Common flaws exist in published cost-effectiveness models of pharmacologic stroke prevention in atrial fibrillation
Limone, B. L., Baker, W. L., Mearns, E. S., White, C. M., Kluger, J., & Coleman, C. I. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.05.013 · Cited by 13
Assessing the capacity of Ghana to introduce health technology assessment: a systematic review of economic evaluations conducted in Ghana
Addo, R., Goodall, S., Hall, J. P., & Haas, M. R. (2020) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462320000689 · Cited by 13
Systematic Review of the Quality of Economic Evaluations in the Otolaryngology Literature
Liu, C. C., Lui, J. T., Paolucci, E. O., & Rudmik, L. R. (2014) · Otolaryngology · doi:10.1177/0194599814556725 · Cited by 13
Grading Economic Evidence
Brunetti, M., Ruiz, F. J., Lord, J. L., Pregno, S., & Oxman, A. D. (2010) · Wiley eBooks · doi:10.1002/9781444320398.ch10 · Cited by 13
A Systematic Review of Health Economic Evaluation on Targeted Therapies for First-Line Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC): Quality Evaluation
Zhao, J., Du, S., Zhu, Y., Liang, Y., Lü, J., & Chang, F. (2020) · Cancer Management and Research · doi:10.2147/cmar.s248471 · Cited by 12
Economic Evaluation of New Oral Anticoagulants in Prevention of Venous Thrombosis Following Joint Replacement Surgery: A Systematic Review
Rezapour, A., Souresrafil, A., & Arabloo, J. (2021) · Clinical Therapeutics · doi:10.1016/j.clinthera.2021.03.012 · Cited by 13
Economic Studies Part 2: Evaluating the Quality
Skelly, A. C., & Henrikson, N. B. (2013) · Evidence-Based Spine-Care Journal · doi:10.1055/s-0033-1341594 · Cited by 12
A Systematic Review of Sources of Outcomes and Cost Data Utilized in Economic Evaluation Research Conducted in the Gulf Cooperation Council
AlAujan, S. S., Almazrou, S. H., & Al-Aqeel, S. (2021) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s285359 · Cited by 12
The state of health economics and pharmaceoconomics research in Russia: a systematic review
Gavaza, P., Shepherd, M. D., Shcherbakova, N., & Khoza, S. (2010) · Journal of Pharmaceutical Health Services Research · doi:10.1111/j.1759-8893.2010.00023.x · Cited by 12
Costing the impact of interventions during pregnancy in the UK: a systematic review of economic evaluations
Relph, S. A., Delaney, L., Melaugh, A., Vieira, M. C., Sandall, J., Khalil, A. A., Pasupathy, D., & Healey, A. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-040022 · Cited by 12
Quality of reporting of economic evaluations in rehabilitation research: a systematic review
Flemming, J., Chojecki, D., Tjosvold, L., Paulden, M., & Armijo-Olivo, S. L. (2020) · Disability and Rehabilitation · doi:10.1080/09638288.2020.1830441 · Cited by 12
A Systematic Review on the Extent and Quality of Pharmacoeconomic Publications for China
Jiang, S., Ma, X., Desai, P., Yang, L., & Rascati, K. L. (2014) · Value in Health Regional Issues · doi:10.1016/j.vhri.2014.02.010 · Cited by 12
Quality of pharmacoeconomic research in China
Ma, H., Jian, W., Xu, T., He, Y., Rizzo, J. A., & Fang, H. (2016) · Medicine · doi:10.1097/md.0000000000005114 · Cited by 12
Evaluation of Quality of Pharmacoeconomic Studies in Asia-Pacific Region and Identification of Influencing Variables
Pandey, P., Pandey, R. D., & Shah, V. (2017) · Value in Health Regional Issues · doi:10.1016/j.vhri.2017.07.007 · Cited by 12
A Systematic Review and Critical Appraisal of Economic Evaluations of Pharmacological Interventions for People with Bipolar Disorder
Mavranezouli, I., & Lokkerbol, J. (2016) · PharmacoEconomics · doi:10.1007/s40273-016-0473-1 · Cited by 13
Short-term economic evaluation of physical activity-based corporate health programs: a systematic review
Bonatesta, L., Palermi, S., Sirico, F., Mancinelli, M., Torelli, P., Russo, E., Annarumma, G., Vecchiato, M., Fernando, F., Gregori, G., et al. (2024) · Journal of Occupational Health · doi:10.1093/joccuh/uiae002 · Cited by 11
Economic Value of Pharmacogenetic Testing for Cancer Drugs with Clinically Relevant Drug-Gene Associations: A Systematic Literature Review
Faruque, F., Noh, H., Hussain, A., Neuberger, E. E., & Onukwugha, E. (2019) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2019.25.2.260 · Cited by 11
High impact health service interventions for attainment of UHC in Africa: A systematic review
Karamagi, H. C., Berhane, A., Kidane, S. N., Nyawira, L., Ani–Amponsah, M., Nyanjau, L., Maoulana, K., Seydi, A. B.-W., Nzinga, J., Dangou, J.-M., et al. (2022) · PLOS Global Public Health · doi:10.1371/journal.pgph.0000945 · Cited by 11
Palliative Care Costs in Different Ambulatory-Based Settings: A Systematic Review
Perea-Bello, A. H., Trapero‐Bertran, M., & Dürsteler, C. (2023) · PharmacoEconomics · doi:10.1007/s40273-023-01336-w · Cited by 11
Health economic evaluation of current vaccination strategies and new vaccines against tuberculosis: a systematic review
Machlaurin, A., van der Pol, S., Setiawan, D., van der Werf, T. S., & Postma, M. J. (2019) · Expert Review of Vaccines · doi:10.1080/14760584.2019.1651650 · Cited by 11
Assessing the Value of the Quality of Health Economic Studies (QHES)
Motheral, B. R. (2003) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2003.9.1.86 · Cited by 11
Research Review: Economic evidence for interventions in children's social care: revisiting the What Works for Children project
Stevens, M., Roberts, H. M., & Shiell, A. (2010) · Child & Family Social Work · doi:10.1111/j.1365-2206.2009.00665.x · Cited by 10
Considering Cost-Effectiveness in Cardiology Clinical Guidelines: Progress and Prospects
Hlatky, M. A. (2016) · Value in Health · doi:10.1016/j.jval.2016.04.019 · Cited by 10
Evaluation of quality of pharmacoeconomic studies involved in traditional Chinese medicine in China
Si, L., Yin, M., Wang, J., Yang, S., Zhang, J., & Wei, L. S. (2020) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2020.1800455 · Cited by 10
What Are the Strength of Recommendations and Methodologic Reporting in Health Economic Studies in Orthopaedic Surgery?
Makhni, E. C., Steinhaus, M. E., Swart, E. F., & Bozic, K. J. (2015) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-015-4369-8 · Cited by 10
Use of Autologous Stem Cells in Lumbar Spinal Fusion: A Systematic Review of Current Clinical Evidence
Buser, Z., Hsieh, P. C., Meisel, H.-J., Skelly, A. C., Brodt, E., Brodke, D. S., Park, J., Yoon, S. T., Wang, J. W.-T., & Degenerative, A. K. (2020) · Global Spine Journal · doi:10.1177/2192568220973190 · Cited by 10
Cost-effectiveness analyses of targeted therapy and immunotherapy for advanced non-small cell lung cancer in the United States: a systematic review
Yu, A., Huang, E., Abe, M., An, K., Park, S., & Park, C. (2021) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2021.1886928 · Cited by 10

Authors: Ofman, J. J., Sullivan, S. D., Neumann, P. J., Chiou, C.-F., Henning, J. M., Wade, S. W., & Hay, J. W.
ORCID: Sullivan, Sean D.
Neumann, Peter J.
Hay, Joel W.
Venue: Journal of Managed Care Pharmacy
Publisher: Academy of Managed Care Pharmacy
Published: 2003-01
Volume: 9
Issue: 1
Pages: 53-61
ISSN: 1083-4087 (ISSN-L)
1944-706X
DOI: 10.18553/jmcp.2003.9.1.53
PMC: PMC10437166
OpenAlex: W2130921523
Cited by: 366
References: 76
Citations by year: 2026: 14 · 2025: 18 · 2024: 18 · 2023: 26 · 2022: 25 · 2021: 39 · 2020: 27 · 2019: 35 · 2018: 17 · 2017: 20 · 2016: 16 · 2015: 21 · 2014: 24 · 2013: 18 · 2012: 11
FWCI: 9.62
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Journal of Managed Care Pharmacy (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
Social Sciences › Sociology and Political Science › Delphi Technique in Research
Keywords: instrument validation, gastroesophageal reflux disease, healthcare decision-making, resource allocation, reporting guidelines, systematic reviews
MeSH terms: Cost-Benefit Analysis, Delivery of Health Care, Humans, United States, Economics, Pharmaceutical

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Examining the Value and Quality of Health Economic Analyses: Implications of Utilizing the QHES

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks